Open original FDA record ↗Recall record
- FDA identifier
- Z-0877-2022
- Company in FDA record
- Hologic, Inc
- FDA classification date
- Apr 6, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Samples, run on a GBS Assay, that have analyte concentrations that are at or near the limit of detection may produce false negative results.
Source facts
- Action
- On 03/18/22, recall notices were sent to customers who were informed that the recalling firm is discontinuing the further sale of the affected GBS Assay for the foreseeable future. Customers were asked to do the following: 1) Discontinue use and destroy affected GBS assay kit lots and respective components. 2) Complete and return the customer response form. Customers with additional questions were encouraged to contact Technical Support at +1 888 484 4747 or +1 858 410 8511 between 5am PDT and 5 pm PDT, or by email at molecularsupport@hologic.com
- Initiated
- 2022-03-18
- Root cause
- Component change control
- Distribution
- US: TX, TN, NY, NV, IN, AR, CA, CT, IL, NH, PA, WA, FL, OR, WV, VA, UT, MA, NJ, MI, PR OUS: CA
- Recall number
- Z-0877-2022
- Recall status
- Open, Classified
- CDRH record ID
- 192684
- FDA classified
- 2022-04-06
- Recall event number
- 89855